Estrogen and progesterone receptors have distinct roles in the establishment of the hyperplastic phenotype in PR-A transgenic mice

Breast Cancer Research

Volumn 11, Issue 5, 2009, Pages

  Simian, Marina ^a,b   Bissell, Mina J ^a   Barcellos Hoff, Mary H ^a,c   Shyamala, Gopalan ^a  

^a LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

^b Instituto de Oncologia Angel H Roffo   (Argentina)

^c NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BROXURIDINE; COLLAGEN TYPE 3; COLLAGEN TYPE 4; ESTROGEN RECEPTOR; FULVESTRANT; GELATINASE A; KALININ; LATENCY ASSOCIATED PEPTIDE; MATRIX METALLOPROTEINASE; MIFEPRISTONE; ONAPRISTONE; PROGESTERONE RECEPTOR A; TRANSFORMING GROWTH FACTOR BETA1; ESTRADIOL; PROGESTERONE; PROGESTERONE RECEPTOR; PROGESTERONE RECEPTOR B;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASEMENT MEMBRANE; BREAST CANCER; BREAST CARCINOGENESIS; BREAST HYPERPLASIA; CANCER HORMONE THERAPY; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; IMAGE ANALYSIS; IMMUNOFLUORESCENCE; MAMMARY GLAND; MOUSE; NONHUMAN; OVARIECTOMY; PHENOTYPE; PRECANCER; PROTEIN DEGRADATION; PROTEIN DEPLETION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; STEADY STATE; TRANSGENIC MOUSE; WILD TYPE; ZYMOGRAPHY; ANIMAL; DRUG EFFECT; GENETICS; HYPERPLASIA; PATHOLOGY; PHYSIOLOGY; UDDER;

ANIMALS; ESTRADIOL; HYPERPLASIA; MAMMARY GLANDS, ANIMAL; MICE; MICE, TRANSGENIC; PROGESTERONE; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE;

EID: 77449109233     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr2408     Document Type: Article

References (34)

1. Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schutz G, Umesono K, Blumberg B, Kastner P, Mark M, Chambon P, Evans RM. The nuclear receptor superfamily: the second decade. Cell 1995, 83:835-839. 10.1016/0092-8674(95)90199-X, 8521507.
2. Tsai MJ, O'Malley BW. Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu Rev Biochem 1994, 63:451-486. 10.1146/annurev.bi.63.070194.002315, 7979245.
3. Shyamala G, Barcellos-Hoff MH, Toft D, Yang X. In situ localization of progesterone receptors in normal mouse mammary glands: absence of receptors in the connective and adipose stroma and a heterogeneous distribution in the epithelium. J Steroid Biochem Mol Biol 1997, 63:251-259. 10.1016/S0960-0760(97)00128-3, 9459191.
4. Lydon JP, DeMayo FJ, Funk CR, Mani SK, Hughes AR, Montgomery CA, Shyamala G, Conneely OM, O'Malley BW. Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities. Genes Dev 1995, 9:2266-2278. 10.1101/gad.9.18.2266, 7557380.
5. Shyamala G, Louie SG, Camarillo IG, Talamantes F. The progesterone receptor and its isoforms in mammary development. Mol Genet Metab 1999, 68:182-190. 10.1006/mgme.1999.2897, 10527668.
6. Shyamala G, Yang X, Silberstein G, Barcellos-Hoff MH, Dale E. Transgenic mice carrying an imbalance in the native ratio of A to B forms of progesterone receptor exhibit developmental abnormalities in mammary glands. Proc Natl Acad Sci USA 1998, 95:696-701. 10.1073/pnas.95.2.696, 18483, 9435255.
7. Shyamala G, Yang X, Cardiff RD, Dale E. Impact of progesterone receptor on cell-fate decisions during mammary gland development. Proc Natl Acad Sci USA 2000, 97:3044-3049. 10.1073/pnas.97.7.3044, 16189, 10737785.
8. Medina D. Biological and molecular characteristics of the premalignant mouse mammary gland. Biochim Biophys Acta 2002, 1603:1-9.
9. Chou YC, Uehara N, Lowry JR, Shyamala G. Mammary epithelial cells of PR-A transgenic mice exhibit distinct alterations in gene expression and growth potential associated with transformation. Carcinogenesis 2003, 24:403-409. 10.1093/carcin/24.3.403, 12663498.
10. Fata JE, Werb Z, Bissell MJ. Regulation of mammary gland branching morphogenesis by the extracellular matrix and its remodeling enzymes. Breast Cancer Res 2004, 6:1-11. 314442, 14680479.
11. Katzenellenbogen BS. Mechanisms of action and cross-talk between estrogen receptor and progesterone receptor pathways. J Soc Gynecol Investig 2000, 7:S33-S37. 10.1016/S1071-5576(99)00058-1, 10732327.
12. Kraus WL, Weis KE, Katzenellenbogen BS. Inhibitory cross-talk between steroid hormone receptors: differential targeting of estrogen receptor in the repression of its transcriptional activity by agonist- and antagonist-occupied progestin receptors. Mol Cell Biol 1995, 15:1847-1857. 230410, 7891678.
13. Talhouk RS, Chin JR, Unemori EN, Werb Z, Bissell MJ. Proteinases of the mammary gland: developmental regulation in vivo and vectorial secretion in culture. Development 1991, 112:439-449.
14. Ewan KB, Oketch-Rabah HA, Ravani SA, Shyamala G, Moses HL, Barcellos-Hoff MH. Proliferation of estrogen receptor-alpha-positive mammary epithelial cells is restrained by transforming growth factor-beta 1 in adult mice. Am J Pathol 2005, 167:409-417. 1603552, 16049327.
15. Shi Y, Massague J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 2003, 113:685-700. 10.1016/S0092-8674(03)00432-X, 12809600.
16. Barcellos-Hoff MH, Ehrhart EJ, Kalia M, Jirtle R, Flanders K, Tsang ML. Immunohistochemical detection of active transforming growth factor-beta in situ using engineered tissue. Am J Pathol 1995, 147:1228-1237. 1869520, 7485387.
17. Ewan KB, Shyamala G, Ravani SA, Tang Y, Akhurst R, Wakefield L, Barcellos-Hoff MH. Latent transforming growth factor-beta activation in mammary gland: regulation by ovarian hormones affects ductal and alveolar proliferation. Am J Pathol 2002, 160:2081-2093. 1850834, 12057913.
18. Williams JM, Daniel CW. Mammary ductal elongation: differentiation of myoepithelium and basal lamina during branching morphogenesis. Dev Biol 1983, 97:274-290. 10.1016/0012-1606(83)90086-6, 6852366.
19. Talhouk RS, Bissell MJ, Werb Z. Coordinated expression of extracellular matrix-degrading proteinases and their inhibitors regulates mammary epithelial function during involution. J Cell Biol 1992, 118:1271-1282. 10.1083/jcb.118.5.1271, 2289583, 1512297.
20. Sympson CJ, Talhouk RS, Alexander CM, Chin JR, Clift SM, Bissell MJ, Werb Z. Targeted expression of stromelysin-1 in mammary gland provides evidence for a role of proteinases in branching morphogenesis and the requirement for an intact basement membrane for tissue-specific gene expression. J Cell Biol 1994, 125:681-693. [published erratum J Cell Biol 1996, 132:following 752], 10.1083/jcb.125.3.681, 2119999, 8175886.
21. Thomasset N, Lochter A, Sympson CJ, Lund LR, Williams DR, Behrendtsen O, Werb Z, Bissell MJ. Expression of autoactivated stromelysin-1 in mammary glands of transgenic mice leads to a reactive stroma during early development. Am J Pathol 1998, 153:457-467. 1852990, 9708806.
22. Sternlicht MD, Lochter A, Sympson CJ, Huey B, Rougier JP, Gray JW, Pinkel D, Bissell MJ, Werb Z. The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis. Cell 1999, 98:137-146. 10.1016/S0092-8674(00)81009-0, 10428026.
23. Koshikawa N, Giannelli G, Cirulli V, Miyazaki K, Quaranta V. Role of cell surface metalloprotease MT1-MMP in epithelial cell migration over laminin-5. J Cell Biol 2000, 148:615-624. 10.1083/jcb.148.3.615, 2174802, 10662785.
24. Leonhardt SA, Edwards DP. Mechanism of action of progesterone antagonists. Exp Biol Med (Maywood) 2002, 227:969-980.
25. Duffy MJ, Maguire TM, Hill A, McDermott E, O'Higgins N. Metalloproteinases: role in breast carcinogenesis, invasion and metastasis. Breast Cancer Res 2000, 2:252-257. 10.1186/bcr65, 138784, 11250717.
26. Wiseman BS, Sternlicht MD, Lund LR, Alexander CM, Mott J, Bissell MJ, Soloway P, Itohara S, Werb Z. Site-specific inductive and inhibitory activities of MMP-2 and MMP-3 orchestrate mammary gland branching morphogenesis. J Cell Biol 2003, 162:1123-1133. 10.1083/jcb.200302090, 2172848, 12975354.
27. Witty JP, Wright JH, Matrisian LM. Matrix metalloproteinases are expressed during ductal and alveolar mammary morphogenesis, and misregulation of stromelysin-1 in transgenic mice induces unscheduled alveolar development. Mol Biol Cell 1995, 6:1287-1303. 301288, 8573787.
28. Bocchinfuso WP, Korach KS. Mammary gland development and tumorigenesis in estrogen receptor knockout mice. J Mammary Gland Biol Neoplasia 1997, 2:323-334. 10.1023/A:1026339111278, 10935020.
29. Nelson CM, Vanduijn MM, Inman JL, Fletcher DA, Bissell MJ. Tissue geometry determines sites of mammary branching morphogenesis in organotypic cultures. Science 2006, 314:298-300. 10.1126/science.1131000, 17038622.
30. Shyamala G, Chou YC, Louie SG, Guzman RC, Smith GH, Nandi S. Cellular expression of estrogen and progesterone receptors in mammary glands: regulation by hormones, development and aging. J Steroid Biochem Mol Biol 2002, 80:137-148. 10.1016/S0960-0760(01)00182-0, 11897499.
31. Rowe RG, Weiss SJ. Breaching the basement membrane: who, when and how?. Trends in Cell Biology 2008, 18:560-574. 10.1016/j.tcb.2008.08.007, 18848450.
32. Graham JD, Yeates C, Balleine RL, Harvey SS, Milliken JS, Bilous AM, Clarke CL. Characterization of progesterone receptor A and B expression in human breast cancer. Cancer Res 1995, 55:5063-5068.
33. Mote PA, Johnston JF, Manninen T, Tuohimaa P, Clarke CL. Detection of progesterone receptor forms A and B by immunohistochemical analysis. J Clin Pathol 2001, 54:624-630. 10.1136/jcp.54.8.624, 1731503, 11477119.
34. Mote PA, Bartow S, Tran N, Clarke CL. Loss of co-ordinate expression of progesterone receptors A and B is an early event in breast carcinogenesis. Breast Cancer Res Treat 2002, 72:163-172. 10.1023/A:1014820500738, 12038707.